This is when your blood clots, and your body's immune system reacts to it. It's like your body is fighting a battle inside your blood vessels. This can happen for many reasons, including things like COVID-19 or sickle cell disease.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Thromboinflammation describes what happens when blood clotting and inflammation switch each other on. Normally, clotting stops bleeding and inflammation fights infection and starts healing. In thromboinflammation the two become linked in a harmful loop: inflamed blood vessels and immune cells make clots more likely, and clots release signals that drive more inflammation. Platelets, the small blood cells that start a clot, sit at the center of this exchange. It is better understood as a process that occurs within other diseases than as a diagnosis on its own. A familiar example is superficial thrombophlebitis, a tender, red, inflamed vein near the skin with a clot inside it. The more serious forms happen out of sight, in large veins and arteries or in the tiny vessels of organs such as the lungs and kidneys, where they can contribute to deep vein clots, heart attacks, strokes and organ damage. A closely related term, immunothrombosis, refers to the protective version: during an infection, clotting helps the immune system trap germs in the bloodstream. Thromboinflammation is what researchers call that response when it becomes excessive or misdirected.
Thromboinflammation is driven by an underlying illness or injury that inflames the lining of blood vessels. Healthy vessel walls actively resist clotting and calm inflammation; when they are damaged or inflamed, they lose that protection. Common settings include serious infections and sepsis, as well as viral infections such as COVID-19, influenza and dengue. It also occurs in sickle cell disease, antiphospholipid syndrome (an autoimmune condition that makes blood clot too easily), preeclampsia during pregnancy, major trauma, severe burns and organ transplant rejection. Long-term inflammatory diseases and atherosclerosis, the buildup of fatty plaque in arteries, are linked to a higher risk of heart attack and stroke partly through this pathway. General clot risk factors add to the picture: being immobile in the hospital or after surgery, cancer, pregnancy, smoking, obesity and a personal or family history of clots. Having one of these conditions does not mean a person will develop harmful clots, but it is a reason doctors watch for them.
There is no single routine test that diagnoses thromboinflammation itself. In practice, doctors identify the underlying condition and look for clots and their effects. When a clot is suspected, a clinician takes a history, examines the person and may order a D-dimer blood test, which measures a breakdown product of clots. A normal result makes a clot unlikely. A high result is not specific, because pregnancy, recent surgery, heart disease, inflammatory conditions such as rheumatoid arthritis, being immobile and older age can all raise it. Imaging confirms where a clot is: ultrasound for the legs and arms, and a CT scan of the chest for the lungs. Other blood tests, such as C-reactive protein (a general marker of inflammation), help track how active the underlying illness is. Newer markers that measure this process more directly are being studied but are not yet part of ordinary care.
Treatment focuses on two things: controlling the illness that is driving the process and preventing or treating clots. Treating an infection, calming an autoimmune flare or managing sickle cell disease can reduce the inflammatory drive behind clotting. Blood thinners (anticoagulants) such as heparin, which is given by injection or IV, or pills such as apixaban (Eliquis) and rivaroxaban (Xarelto), stop clots from growing and new ones from forming. Their main trade-off is bleeding, and the right dose depends on the situation. In hospitalized COVID-19, for example, guidelines favor a full treatment dose for some moderately ill patients but a lower preventive dose for the critically ill, because bleeding risk changes the balance. Simple measures, such as getting up and moving as soon as possible after illness or surgery and wearing compression stockings after surgery, also lower clot risk. Treating the inflammation side directly is an active area of research. One established example comes from heart disease: low-dose colchicine (Lodoco), an older anti-inflammatory medicine, is approved to lower the risk of heart attack and stroke in adults with atherosclerosis or several heart risk factors. Because it dampens the immune response, it can increase the chance of some infections, and it interacts with a number of common medicines. Most other treatments aimed specifically at thromboinflammation are still experimental.
What happens depends mostly on the underlying condition. For many people, such as someone hospitalized with a severe infection, thromboinflammation is a short-lived problem that settles as the illness is treated, often with a course of preventive blood thinner while they are least mobile. For people with an ongoing condition, such as sickle cell disease, antiphospholipid syndrome or heart disease, it is a long-term risk that shapes care. Some will take a blood thinner or an antiplatelet medicine for months or for life, which means watching for bleeding, checking with the prescriber before taking other medicines that also thin the blood, such as aspirin, and keeping regular follow-up appointments. Research into thromboinflammation is moving quickly, and it has changed how doctors think about clots in conditions such as COVID-19, sepsis and stroke. For now, though, everyday care still centers on treating the underlying disease well and keeping clot risk under control.
If you have a condition linked to clotting and inflammation, talk with your care team at a routine visit about your personal clot risk, whether you need preventive treatment and what to do before surgery, long trips or pregnancy. Call your care team right away if you notice new swelling, pain, tenderness or warmth in one leg or arm, which can signal a deep vein clot, or if you take a blood thinner and have unusual bleeding or bruising. Call 911 for sudden shortness of breath, chest pain that may worsen with a deep breath, coughing up blood or fainting, which can mean a clot has reached the lungs. Also call 911 for signs of a stroke, such as sudden weakness or numbness on one side, trouble speaking or a sudden severe headache.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Thromboinflammation is like, what's helped you, or ask the community a question.